BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 15721372)

  • 1. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal nanomedicines: an emerging field.
    Fenske DB; Chonn A; Cullis PR
    Toxicol Pathol; 2008 Jan; 36(1):21-9. PubMed ID: 18337218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W; Huang Z; MacKay JA; Grube S; Szoka FC
    J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes.
    Maurer N; Wong KF; Stark H; Louie L; McIntosh D; Wong T; Scherrer P; Semple SC; Cullis PR
    Biophys J; 2001 May; 80(5):2310-26. PubMed ID: 11325732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs.
    Felnerova D; Viret JF; Glück R; Moser C
    Curr Opin Biotechnol; 2004 Dec; 15(6):518-29. PubMed ID: 15560978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
    McCormack B; Gregoriadis G
    J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of liposomes as injectable-drug delivery systems.
    Ostro MJ; Cullis PR
    Am J Hosp Pharm; 1989 Aug; 46(8):1576-87. PubMed ID: 2672806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.
    Venugopalan P; Jain S; Sankar S; Singh P; Rawat A; Vyas SP
    Pharmazie; 2002 Oct; 57(10):659-71. PubMed ID: 12426945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of doxorubicin liposomes.
    Niu G; Cogburn B; Hughes J
    Methods Mol Biol; 2010; 624():211-9. PubMed ID: 20217598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).
    Hope MJ; Mui B; Ansell S; Ahkong QF
    Mol Membr Biol; 1998; 15(1):1-14. PubMed ID: 9595549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulating protein into preformed liposomes by ethanol-destabilized method.
    Wang CH; Huang YY
    Artif Cells Blood Substit Immobil Biotechnol; 2003 Aug; 31(3):303-12. PubMed ID: 12906311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
    Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
    J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations.
    Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC
    Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures.
    Semple SC; Klimuk SK; Harasym TO; Dos Santos N; Ansell SM; Wong KF; Maurer N; Stark H; Cullis PR; Hope MJ; Scherrer P
    Biochim Biophys Acta; 2001 Feb; 1510(1-2):152-66. PubMed ID: 11342155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Diffusible-PEG-lipid stabilized plasmid lipid particles".
    MacLachlan I; Cullis P
    Adv Genet; 2005; 53():157-88. PubMed ID: 16240993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-circulating vectors for the systemic delivery of genes.
    Fenske DB; MacLachlan I; Cullis PR
    Curr Opin Mol Ther; 2001 Apr; 3(2):153-8. PubMed ID: 11338928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
    Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery.
    Heyes J; Hall K; Tailor V; Lenz R; MacLachlan I
    J Control Release; 2006 May; 112(2):280-90. PubMed ID: 16603272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.